StockTalk: How are ASX medtechs responding to skyrocketing healthcare spending?

StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses skyrocketing healthcare spending and its impact on the medtech sub-sector.

Populating the expert panel this week is Jason Waller, CEO & MD of Intelicare (ASX:ICR), Geoff Pocock, executive director of Osteopore (ASX:OSX) and Marjan Mikel, CEO & MD of Respiri (ASX:RSH).

The group discusses a range of topics, including how the medtech sector has reacted to increased funding, if the trend will continue post COVID-19, which firms are capitalising, which regions are primed for medtech adoption, the question of affordability and more.

So tune in above to hear the panel discuss these questions.